Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Paul Ausick | Oct 27, 2011 at 4:11 PM EDT

24/7 Closing Bell (F, NFLX, ITRI, V, RRC, PG, CL, XOM, OXY, ABX, JCI, BMY, MO, QUIK, KELYB, LDK, CENX, MDR, AVP)

The DJIA jumped above 12,000 in the opening minutes of trading this morning and had topped 12,200 by mid-afternoon. European…

Paul Ausick | Oct 20, 2011 at 10:58 AM EDT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…

Jon C. Ogg | Oct 19, 2011 at 10:18 AM EDT

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public. So what…

Jon C. Ogg | Oct 12, 2011 at 2:10 PM EDT

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…

Douglas A. McIntyre | Oct 6, 2011 at 7:27 PM EDT

America’s Recession-Proof Companies

With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there…

Jon C. Ogg | Sep 22, 2011 at 8:14 AM EDT

Top Analyst Upgrades & Downgrades (AMSF, BMY, BRCM, CBST, HOV, INTC, JNJ, KBH, LEN, LULU, MAKO, NFLX, ASGN, OKS, TSLA, TWX, YHOO, YOKU)

Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | Sep 19, 2011 at 8:19 AM EDT

Top Analyst Upgrades & Downgrades (AMAT, CAR, BMY, BRCM, CTRN, CL, ENB, HUN, LRCX, MU, PIR, RENN, TEF)

Jon OggThese are some of this Monday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | Aug 29, 2011 at 12:39 PM EDT

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in…

Douglas A. McIntyre | Aug 29, 2011 at 6:17 AM EDT

Media Digest (8/29/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

LG Display (NYSE: LPL) cuts capital expenditures as demand for LCD screens is hurt by tablet PC sales. (Reuters) Samsung…

Douglas A. McIntyre | Aug 4, 2011 at 9:26 AM EDT

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability.…

Jon C. Ogg | Jun 16, 2011 at 8:10 AM EDT

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key…

Jon C. Ogg | Jun 9, 2011 at 3:39 PM EDT

Screening the Highest Dividends in Defensive Stocks (MO, RAI, LO, KMB, LLY, HNZ, CAG, TAP, DPS, AWK)

We may have just witnessed an oversold bounce in the stock market, or we may be in for more days…

Jon C. Ogg | May 11, 2011 at 8:29 AM EDT

Top Analyst Upgrades & Downgrades (AIXG, BMY, DKS, HEV, GNC, HMY, HBAN, HUN, JASO, JNJ, NTAP, NYB, QIHU, SBUX, UTI, WMB)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday…

Jon C. Ogg | Mar 28, 2011 at 10:01 AM EDT

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval…

Jon C. Ogg | Feb 6, 2011 at 8:55 AM EST

The Coming Week’s Must See Stock Events (ANN, VOXX, BEC, BMY, SU, CNQ, DIN, GS, EGPT, ICGE, OTEX, JDSU, KMP, KMR, KV-A, LULU, MU, NDAQ, OREX, QCOR, SIRI)

Earnings season may still be in force, but we are looking for the coming week’s top coming events that could…

1 … 31 32 33 34 35 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

24/7 Closing Bell (F, NFLX, ITRI, V, RRC, PG, CL, XOM, OXY, ABX, JCI, BMY, MO, QUIK, KELYB, LDK, CENX, MDR, AVP)

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

America’s Recession-Proof Companies

Top Analyst Upgrades & Downgrades (AMSF, BMY, BRCM, CBST, HOV, INTC, JNJ, KBH, LEN, LULU, MAKO, NFLX, ASGN, OKS, TSLA, TWX, YHOO, YOKU)

Top Analyst Upgrades & Downgrades (AMAT, CAR, BMY, BRCM, CTRN, CL, ENB, HUN, LRCX, MU, PIR, RENN, TEF)

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

Media Digest (8/29/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Screening the Highest Dividends in Defensive Stocks (MO, RAI, LO, KMB, LLY, HNZ, CAG, TAP, DPS, AWK)

Top Analyst Upgrades & Downgrades (AIXG, BMY, DKS, HEV, GNC, HMY, HBAN, HUN, JASO, JNJ, NTAP, NYB, QIHU, SBUX, UTI, WMB)

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

The Coming Week’s Must See Stock Events (ANN, VOXX, BEC, BMY, SU, CNQ, DIN, GS, EGPT, ICGE, OTEX, JDSU, KMP, KMR, KV-A, LULU, MU, NDAQ, OREX, QCOR, SIRI)

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

24/7 Closing Bell (F, NFLX, ITRI, V, RRC, PG, CL, XOM, OXY, ABX, JCI, BMY, MO, QUIK, KELYB, LDK, CENX, MDR, AVP)

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

America’s Recession-Proof Companies

Top Analyst Upgrades & Downgrades (AMSF, BMY, BRCM, CBST, HOV, INTC, JNJ, KBH, LEN, LULU, MAKO, NFLX, ASGN, OKS, TSLA, TWX, YHOO, YOKU)

Top Analyst Upgrades & Downgrades (AMAT, CAR, BMY, BRCM, CTRN, CL, ENB, HUN, LRCX, MU, PIR, RENN, TEF)

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

Media Digest (8/29/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Screening the Highest Dividends in Defensive Stocks (MO, RAI, LO, KMB, LLY, HNZ, CAG, TAP, DPS, AWK)

Top Analyst Upgrades & Downgrades (AIXG, BMY, DKS, HEV, GNC, HMY, HBAN, HUN, JASO, JNJ, NTAP, NYB, QIHU, SBUX, UTI, WMB)

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

The Coming Week’s Must See Stock Events (ANN, VOXX, BEC, BMY, SU, CNQ, DIN, GS, EGPT, ICGE, OTEX, JDSU, KMP, KMR, KV-A, LULU, MU, NDAQ, OREX, QCOR, SIRI)

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It